Freeline presents new Haemophilia B data at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Meeting
July 13, 2020 11:45 ET
|
Freeline Therapeutics
- Updated FLT180a data in the B-AMAZE study in severe Haemophilia B patients demonstrated the potential for sustained normal FIX activity levels - - Additional data were presented in 5 poster...
Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Commercial Officer
July 09, 2020 07:30 ET
|
Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, July 09, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Michael...
Abeona Therapeutics Reinitiates Enrollment in EB-101 Pivotal Phase 3 VIITAL™ Study in RDEB after COVID-19 Related Pause and Announces Progress in Patient Enrollment in MPS III Studies
July 08, 2020 07:30 ET
|
Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, July 08, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced recent updates on its clinical...
Freeline Announces Additional Financing Plans
June 30, 2020 02:00 ET
|
Freeline Logo
LONDON, June 30, 2020 (GLOBE NEWSWIRE) -- Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced that it expects to consider...
Freeline Closes $120 Million Series C Financing Round
June 30, 2020 02:00 ET
|
Freeline Logo
LONDON, June 30, 2020 (GLOBE NEWSWIRE) -- Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million...
Freeline announces acceptance of Late Breaking Abstract at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Meeting
June 29, 2020 09:00 ET
|
Freeline Logo
- Updated data will be presented in an oral presentation on the efficacy and safety of AAV gene therapy FL180a in the B-AMAZE study in severe haemophilia B patients - - Additional data will be...
EHang Reports First Quarter 2020 Unaudited Financial Results
May 29, 2020 06:00 ET
|
EHang Holdings Limited
- Solid Results Despite Pandemic Challenges- YoY Growth in Revenue, Gross Margin and Air Mobility Solutions- Global Progress: U.S., Spain, Norway and China- Pandemic Reveals New Applications in...
EHang Holdings Limited Announced Appointment of Independent Director
May 28, 2020 08:30 ET
|
EHang Holdings Limited
GUANGZHOU, China, May 28, 2020 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang to Participate in Upcoming Investor Conferences
May 25, 2020 08:30 ET
|
EHang Holdings Limited
GUANGZHOU, China, May 25, 2020 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang to Report First Quarter 2020 Unaudited Financial Results on May 29, 2020
May 21, 2020 08:30 ET
|
EHang Holdings Limited
GUANGZHOU, China, May 21, 2020 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company” ) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (AAV) technology platform company,...